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Conclusions: Many genes are relevant for the regeneration of joint damage
in the newt. Some are well known and can also be found in mammals.
Functional validations might help to move closer towards novel therapies
at least in part also driven by endogenously induced regeneration.
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INTERLEUKIN 1 β (IL-1β) AND RESISTIN STIMULATE CHEMOKINE GENE
EXPRESSION BY ORDERED COMBINATORIAL BINDING OF TRANSCRIPTION
FACTORS C/EBPβ AND NF-κB
Z. Zhang1,2, J.L. Bryan1, E. DeLassus1, L.J. Sandell1
1Washington Univ. Sch. of Med., St.Louis, MO; 2First Aﬃliated Hosp. of Sun
Yat-sen Univ., Guangzhou, China
Purpose: IL-1β and the adipokine, resistin, are present in synovial joints
after injury. In vitro they stimulate a large set of chemokines which, as
mediators of cell recruitment, are known to be important in inﬂamma-
tory diseases, including rheumatoid arthritis (RA) and osteoarthritis (OA).
Toward the goal of regulating early events that lead to osteoarthritis, we
have investigated the mechanism by which chemokines are up regulated
in human articular chondrocytes.
Methods: Human articular chondrocytes were used to investigate the
response to IL-1β and the adipokine, resistin. The expression of
CCAAT/enhancer-binding protein β (C/EBPβ), and nuclear factor kappa
B (NF-κB) isoforms, p50, p65, rel-B, c-rel, were tested by quantitative
real-time polymerase chain reaction (qPCR) and western blotting. The
function of C/EBPβ and NF-κB on the chemokine genes, CCL3 and CCL4,
was examined by electrophoretic mobility shift assays (EMSA), chromatin
immunoprecipitation (ChIP), mutation, small interfering RNAs (siRNA),
pNF-κB reporter transfection, and NF-κB inhibitor (IKK-NBD) and C/EBPβ
inhibitor (SB303580) treatments. The co-regulation of C/EBPβ and NF-κB in
time was investigated by transfection, speciﬁc inhibition, and subcellular
localization with or without IL-1β and resistin stimulation.
Results: IL-1β and resistin are additive in their regulation of chemokine
genes. The expression of C/EBPβ and NF-κB isoforms, c-rel and p50, were
increased by IL-1β and resistin in human chondrocytes. The direct in-
volvement of C/EBPβ and NF-κB was demonstrated by DNA binding and
mutation of the binding domain in target genes, CCL3 and CCL4. C/EBPβ
regulated basal activity and the binding steadily increased over time up
to 24 hrs with IL-1β or resistin. In contrast, NF-κB did not regulate basal
activity of CCL3 and CCL4, but was up-regulated upon induction with IL-1β
or resistin, peaking at 8 hrs. C/EBPβ and NF-κB co-enhance the CCL3 and
CCL4 expression and inhibition of C/EBPβ or NF-kB activity was additive.
Figure 1. Subcellular localization of C/EBPβ and NF-κB isoform c-Rel in reponse to IL-1β (1
ng/ml) and resistin (100 ng/ml).
Figure 2. The potential transcriptional model for the up-regulation of chemokine genes in
human chondrocytes.
The timing of transcription factor activation in chondrocytes was conﬁrmed
by subcellular localization of C/EBPβ and c-rel by immunoﬂuorescence
microscopy (Fig. 1). A model of this regulation is shown in Fig. 2.
Conclusion: IL-1β and resistin both play a role in induction of chemokine
synthesis. The transcription factors, C/EBPβ and NF-κB are both involved
in the up-regulation of chemokine genes in human chondrocytes in a
time-ordered manner: NF-κB provides an initial up regulation and C/EBPβ
sustains increased gene expression. Thus, regulation of inﬂammation in
OA will need to account for resistin as well as IL-1β and the function
of C/EBPβ as well as NF-κB in gene regulation. Our results suggest that
chemokine genes in tissues such as cartilage, may be regulated differently
than in inﬂammatory cascades in circulating cells with more emphasis
on control by transcription factors other than NF-κB, particularly C/EBPβ.
Lastly, a newest report indicates that mice lacking C/EBPβ are protected
from OA. Our results shed light on the mechanism of action of this pivotal
transcription factor.
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INHIBITION OF HYPOXIA-INDUCIBLE FACTOR TARGETTING PROYL
HYDROXYLASE DOMAIN-CONTAINING PROTEIN 2 (PHD2) ENHANCES
MATRIX SYNTHESIS BY HUMAN CHONDROCYTES
B.L. Thoms, C.L. Murphy
Kennedy Inst. of Rheumatology. Imperial Coll. London, London, United
Kingdom
Purpose: Human articular cartilage is an avascular tissue, and therefore
functions in a hypoxic environment. Chondrocytes have adapted to this and
actually use hypoxia to drive tissue-speciﬁc functions. We have previously
shown that hypoxia enhances cartilage matrix synthesis in human chon-
drocytes, speciﬁcally through Hypoxia Inducible Factor 2-alpha (HIF-2α)
mediated upregulation of master regulator transcription factor SOX9, which
in turn drives expression of the main cartilage-speciﬁc extracellular matrix
genes. Under normoxic conditions the HIF-α subunit is hydroxylated on
speciﬁc conserved proline residues by proyl-hydroxylase domain enzymes
(PHDs). This hydroxylation signals the α-subunit’s polyubiquitination and
subsequent degradation. PHDs are the direct oxygen sensors of the cell
requiring molecular oxygen as a co-substrate. Here we have investigated
the regulation of HIF-α isoforms by hydroxylases using siRNA against
PHD1/PHD2/PHD3 with the aim of stabilising HIF-2α, up-regulating SOX9
and increasing cartilage matrix deposition.
Methods: Healthy human articular chondrocytes (HACs) were cultured as
a monolayer at 20% or 1% oxygen. Hydroxylases were broadly inhibited
using either dimethyloxalylglycine (DMOG) or speciﬁcally inhibited using
siRNA. The resulting HIF-α stabilization was assessed using western blot
and the expression of chondrocyte markers (SOX9) and key cartilage
extracellular matrix proteins (COL2A1, COL9A1, COL11A2 and AGGRECAN)
using real-time PCR and western blot.
Results: We report the successful knockdown of PHD1/2/3 in freshly
isolated and passaged chondrocytes. PHD2 was identiﬁed as the dominant
isoenzyme in HACs regulating HIF-2α stability in human chondrocytes.
Moreover, speciﬁc inhibition of PHD2 using RNAi-mediated depletion
